Morphic Holding Inc. [MORF] stock is trading at $31.93, up up 11.64%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MORF shares have gain 19.10% over the last week, with a monthly amount glided 35.41%, and seem to be holding up well over a long-time horizon.
On 3, August 2022, Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2022. In a post published today on Yahoo Finance, Continued enrollment of EMERALD-1 phase 2a trial of MORF-057 in patients with ulcerative colitis.
From an analyst’s perspective:
Morphic Holding Inc. [NASDAQ: MORF] stock has seen the most recent analyst activity on July 20, 2022, when SVB Leerink initiated its Outperform rating and assigned the stock a price target of $45. Previously, Canaccord Genuity started tracking the stock with Buy rating on March 31, 2022, and set its price target to $68. On February 11, 2022, BTIG Research initiated with a Buy rating and assigned a price target of $64 on the stock. Wells Fargo started tracking the stock assigning a Overweight rating and suggested a price target of $81 on December 08, 2021. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $35 as its price target on October 26, 2020. In a note dated July 22, 2019, Jefferies initiated an Buy rating.
Morphic Holding Inc. [MORF] stock has fluctuated between $19.23 and $68.75 over the past year. Currently, Wall Street analysts expect the stock to reach $65.29 within the next 12 months. Morphic Holding Inc. [NASDAQ: MORF] shares were valued at $31.93 at the most recent close of the market. An investor can expect a potential return of 104.48% based on the average price forecast.
Analyzing the MORF fundamentals
Morphic Holding Inc. [NASDAQ:MORF] reported sales of 2.38 billion for the most recent quarter, which represents a drop of -27.30%. Gross Margin for this corporation currently stands at +94.80% with Operating Margin at -484.02%, Pretax Margin comes in at -482.68%, and Net Margin reading is -482.68%.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 29.88 points at the first support level, and at 27.82 for the second support level. However, for the 1st resistance point, the stock is sitting at 33.01, and for the 2nd resistance point, it is at 34.08.
Morphic Holding Inc. [MORF] reported earnings per share of -$0.85 for its fiscal quarter that ended on 3/30/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.81/share, meaning a difference of $-0.04 and a surprise factor of -4.90%. By comparison, the stated earnings for the previous quarter ended on 12/30/2021 were -$0.58 per share as compared to estimates of -$0.49 per share, a difference of $-0.09 representing a surprise of -18.40%.
Ratios To Look Out For
For context, Morphic Holding Inc.’s Current Ratio is 8.90. Further, the Quick Ratio stands at 10.93, while the Cash Ratio is 10.67. Considering the valuation of this stock, the price to sales ratio is 85.69, the price to book ratio is 5.22.
Transactions by insiders
Insider trading, which has resulted in 1 insider purchases of 9,600 shares and 0 insider sales of 0 shares in the past three months, is now the topic of our analysis. Recent insider trading involved Rogers Bruce, Chief Scientific Officer, that happened on Apr 01 when 10000.0 shares were sold. CFO and COO, SCHEGERIN MARC completed a deal on Nov 01 to sell 5477.0 shares. Meanwhile, CFO and COO SCHEGERIN MARC sold 37.0 shares on Oct 26.